The mutational status of TP53 was analyzed because genetic alternations in KRAS, TP53, and SMAD4 play key roles in the tumorigenesis of pancreatic ductal adenocarcinoma [41–43]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.